SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONS
2. ASML
3. BSX
4. ODFL
5. USO
6. LAD
7. SPIR
8. ROIV
9. ORCL
10. CRCL

Go back to SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies
(NASDAQ: SPRC) Delayed: 5.29 --0 (-0%)
Previous Close $5.29    52 Week High $ 
Open $5.29    52 Week Low $ 
Day High $5.29    P/E N/A 
Day Low $5.29    EPS $ 
Volume 15